Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
CE · NYSE · United States · Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)
In shortCelanese Corp is loss-making, generates cash and carries heavy debt, with revenue shrinking (−7.1% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -8.2% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -12.2% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -25.4% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -4.4% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.55× | 62/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 3.11× | 0/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | – | n/a |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -1.12× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 2.09 | 25/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 8.4% | 54/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 23.5% | 24/100 |
| Operating margin volatility | 14.1% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -0.4% | 14/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 8,537 | 9,673 | 10,926 | 10,268 | 9,544 |
| Cost of revenue | 5,855 | 7,293 | 8,343 | 7,932 | 7,592 |
| Gross profit | 2,682 | 2,380 | 2,583 | 2,336 | 1,952 |
| Research & development | 86 | 112 | 146 | 130 | 125 |
| Selling, general & admin | 633 | 824 | 1,077 | 1,033 | 899 |
| Operating income | 1,946 | 1,378 | 1,665 | (720) | (786) |
| Interest expense | 91 | 405 | 720 | 676 | 701 |
| Pre-tax income | 2,248 | 1,421 | 1,161 | (1,019) | (1,220) |
| Income tax | 330 | (489) | (795) | 507 | (90) |
| Net income | 1,890 | 1,894 | 1,943 | (1,542) | (1,165) |
| Diluted EPS | $16.86 | $17.34 | $17.76 | −$14.11 | −$10.64 |
| Diluted shares (millions) | 112 | 109 | 109 | 109 | 110 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
2.09 Grey zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
5/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026